BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 25, 2008
View Archived Issues
Novel microtubule-stabilizing drug improves neurofibrillary Tau pathology in vitro and in vivo
Read More
Novel NMDA receptor modulator shows neuroprotection against ethanol withdrawal, consumption
Read More
Novel therapeutic agents for cardiovascular disorders imparted in recent patent literature
Read More
Sanofi-aventis reports preclinical data of novel trioxaquine candidate for malaria
Read More
Long-term retreatment of HBV patients with entecavir effective
Read More
Multiple doses of MK-7009 safe in HCV patients
Read More
Oncolytics Biotech presents clinical results with its novel oncolytic reovirus type 3 Dearing
Read More
New neuropsychiatric agents reported
Read More
Recent Daiichi Sankyo patent discloses novel antithrombotic agents
Read More
EMEA recommends the suspension of the marketing authorization of Ionsys
Read More
Moberg reports results from phase III clinical study of K-101 for nail fungus
Read More
Resolvyx to initiate phase I/II clinical trial of RX-10045 in moderate to severe dry eye
Read More
European Commission withdraws Schering-Plough's marketing authorization for Viraferon
Read More
Lilly completes cash tender offer for ImClone Systems
Read More
Aeolus initiates animal study of AEOL-10150 in damage to the lungs due to radiation
Read More
CHMP recommends approval of Enbrel for severe plaque psoriasis in pediatric patients
Read More
Genentech and Roche report results from RIBBON 1 phase III clinical study of Avastin
Read More
FDA grants pralatrexate orphan drug status for diffuse large B-cell lymphoma
Read More
Further explanation of CHMP's negative opinion for Santhera's Sovrima for Friedreich's ataxia
Read More
CHMP issues positive opinion for Stelara in plaque psoriasis
Read More
Essentialis completes patient enrollment in phase II DCCR trial
Read More
Factor IXFc receives FDA orphan drug status for hemophilia B
Read More
FDA accepts DX-88 filing and grants priority review for hereditary angioedema
Read More
Valdoxan receives CHMP positive opinion for major depressive disorder
Read More
Xenazine tablets available in U.S. for chorea associated with HD
Read More